Introduction: The incidence, treatment, and outcome of urethral recurrence (UR) after radical cystectomy (RC) for muscle-invasive bladder cancer with orthotopic neobladder in women have rarely been addressed in the literature. Patients and Methods: A total of 12 patients (median age at recurrence: 60 years) who experienced UR after RC with an orthotopic neobladder were selected for this study from a cohort of 456 women from participating institutions. The primary clinical and pathological characteristics at RC, including the manifestation of the UR and its treatment and outcome, were reviewed. Results: The primary bladder tumors in the 12 patients were urothelial carcinoma in 8 patients, squamous cell carcinoma and adenocarcinoma in 1 patient each, and mixed histology in 2 patients. Three patients (25%) had lymph node-positive disease at RC. The median time from RC to the detection of UR was 8 months (range 4-55). Eight recurrences manifested with clinical symptoms and 4 were detected during follow-up or during a diagnostic work-up for clinical symptoms caused by distant metastases. Treatment modalities were surgery, chemotherapy, radiotherapy, and bacillus Calmette-Guérin urethral instillations. Nine patients died of cancer. The median survival after the diagnosis of UR was 6 months. Conclusions: UR after RC with an orthotopic neobladder in females is rare. Solitary, noninvasive recurrences have a favorable prognosis when detected early. Invasive recurrences are often associated with local and distant metastases and have a poor prognosis.

Keywords:
Bladder cancer, Cystectomy, Female, Relapse, Treatment outcome, Urethra
1.
Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666-675.
2.
Roghmann F, Sukumar S, Ravi P, et al: Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care. Urol Int 2014;92:27-34.
3.
Berger I, Martini T, Wehrberger C, et al: Perioperative complications and 90-day mortality of radical cystectomy in the elderly (75+): a retrospective, multicentre study. Urol Int DOI: 10.1159/000357127.
4.
Stein JP, Penson DF, Wu SD, et al: Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. J Urol 2007;178:756-760.
5.
Van Poppel H, Sorgeloose T: Radical cystectomy with or without urethrectomy? Crit Rev Oncol Hematol 2003;47:141-145.
6.
Stenzl A, Höltl L: Orthotopic bladder reconstruction in women - what we have learned over the last decade. Crit Rev Oncol Hematol 2003;47:147-154.
7.
Gakis G, Ali-El-Dein B, Babjuk M, et al: A multi-institutional study on risk factors of urethral recurrence in female patients with ileal neobladder. Eur Urol Suppl 2012;11:e608a.
8.
Stenzl A, Bartsch G, Rogatsch H: The remnant urothelium after reconstructive bladder surgery. Eur Urol 2002;41:124-131.
9.
Stein JP, Clark P, Miranda G, et al: Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 2005;173:1163-1168.
10.
Boorjian SA, Kim SP, Weight CJ, et al: Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol 2011;60:1266-1272.
11.
Hassan JM, Cookson MS, Smith JA Jr, et al: Urethral recurrence in patients following orthotopic urinary diversion. J Urol 2004;172:1338-1341.
12.
Nieder AM, Sved PD, Gomez P, et al: Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring. Urology 2004;64:950-954.
13.
Sherwood JB, Sagalowsky AI: The diagnosis and treatment of urethral recurrence after radical cystectomy. Urol Oncol 2006;24:356-361.
14.
Akkad T, Gozzi C, Deibl M, et al: Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. J Urol 2006;175:1268-1271.
15.
Ali-el-Dein B, Abdel-Latif M, Ashamallah A, et al: Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study. J Urol 2004;171:275-278.
16.
Stein JP, Hertz J, Nichols PW: Urethral recurrence in a woman after continent orthotopic urinary diversion for bladder cancer. Urology 2008;71:755.e1-755.e2.
17.
Jones J, Melchior SW, Gillitzer R, et al: Urethral recurrence of transitional cell carcinoma in a female patient after cystectomy and orthotopic ileal neobladder. J Urol 2000;164:1646.
18.
Gakis G, Efstathiou J, Lerner SP, et al: ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013;63:45-57.
19.
Stein JP, Penson DF, Lee C, et al: Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J Urol 2009;181:2052-2059.
20.
Varol C, Thalmann GN, Burkhard FC, et al: Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol 2004;172:937-942.
21.
Volkmer BG, Kuefer R, Bartsch GC, et al: Oncological follow up after radical cystectomy for bladder cancer - is there any benefit? J Urol 2009;181:1587-1593.
22.
Giannarini G, Kessler TM, Thoeny HC, et al: Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 2010;58:486-494.
23.
Taylor JM, Spiess PE, Kassouf W, et al: Management of urethral recurrence after orthotopic urinary diversion. BJU Int 2010;106:56-61.
24.
Yamashita S, Hoshi S, Ohyama C, et al: Urethral recurrence following neobladder in bladder cancer patients. Tohoku J Exp Med 2003;199:197-203.
25.
Yossepowitch O, Dalbagni G, Golijanin D, et al: Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 2003;169:177-181.
26.
Stenzl A, Jarolim L, Coloby P, et al: Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. Cancer 2001;92:1864-1871.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.